Inovio expands executive leadership to prepare for commercial operations

Plymouth meeting, pa., nov. 5, 2021 /prnewswire/ -- inovio (nasdaq: ino), a biotechnology company focused on bringing to market precisely designed dna medicines to treat and protect people from infectious diseases, cancer, and hpv-associated diseases, today announced the strategic appointments of new leaders designed to position inovio for growth and upcoming commercial operations.
INO Ratings Summary
INO Quant Ranking